SCHEMBL29704392

SCHEMBL29704392

Cn1cc(-c2cc3c(cc2C(F)F)N(c2ccc4c(c2)c(C(=O)O)cn4C)CCC3)cn1

nearest known ligand 0.84

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CREBBP Q92793 20/20 0.84
BRD4 O60885 3/20 0.68
EP300 Q09472 2/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19644119 1.00 CREBBP (0.84) CREBBPBRD4EP300
SCHEMBL19644307 0.91 CREBBP (1.00) CREBBPBRD4EP300
SCHEMBL29704383 0.91 CREBBP (1.00) CREBBPBRD4EP300
SCHEMBL19657680 0.88 CREBBP (0.83) CREBBPBRD4EP300
SCHEMBL19644425 0.88 CREBBP (0.75) CREBBPBRD4EP300
SCHEMBL19657356 0.87 CREBBP (0.72) CREBBPBRD4EP300
SCHEMBL29704502 0.86 CREBBP (0.84) CREBBPBRD4EP300
SCHEMBL19657352 0.86 CREBBP (0.85) CREBBPBRD4EP300
SCHEMBL19643469 0.86 CREBBP (0.84) CREBBPBRD4EP300
SCHEMBL29704370 0.85 CREBBP (0.68) CREBBPBRD4EP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115028617-A Heterocyclic inhibitors of CBP/EP300 and their use in the treatment of cancer 基因泰克公司 2022-09-09 CN disclosed
CN-109476641-B Heterocyclic inhibitors of CBP/EP300 and their use in the treatment of cancer 基因泰克公司 2022-07-05 CN disclosed